among these , 55.1 % ( 49/89 ) of the sera from patients with breast cancer reacted with mmt cells , whereas 60 % ( 3/5 ) of the sera from patients with benign mammary hyperplasia ( 2 of 3 mastopathies , 1 of 2 cystosarcoma phyllodes ) , 30 % ( 12/40 ) of the patients with other than breast cancer ( 4 of 14 stomach cancers , 6 of 20 uterine cancers , 1 of 3 lung cancers , 1 of 3 rectum cancers ) , and 26.5 % ( 18/68 ) of the sera from apparently healthy women showed positive reaction with mmt cells .
C0007634
mmt cells
C0010701
cystosarcoma phyllodes